
A pharmaceutical business management game.
Revenue comes from in-game items and microtransactions, which our price-based model doesn't estimate. Copies below reflect the player base, not paid sales.
Media

About
Genres
Stats
Languages: English
Engagement
Reviews
Themes across 42 recent reviews and how positive each mention is. A keyword signal, not full sentiment analysis.
Reviews
hard asf, but good i love it.
i got sued like eight times in the first year and i didn't even do anything
Very cool game. It does get a bit frustrating though. I took 4 hours on my first run, and only got to 2012 Dec 31 (The game was paused for most of the time, that's why it took so long). You need to reach 2020 to win. My main issue is how annoying the lawsuits are, they are a bit too harsh. I had my lawyers one level above my scientists for the whole run, and still could do no research because of the lawsuits. And the advertising is hard to do as well, as it makes the public trust low and has little effect, although I think it is still more balanced than doing research. Maybe those problems came from my playstyle. But they did take away from my overall enjoyment in the game. Would recommend for an afternoon of fun now and then, but would not consider it a game I would regularly revisit.
Related
Related
Trends
Concurrent players on Steam, sampled daily since tracking started.
Hours played at review time, across 43 reviews with recorded playtime.
positive critical· bar length = how often the theme comes up
Please fix the game bro I beg, Its a good game but its litterally known to be impossible without cheating
fun game about sellin DRUGS
love this game, keep updating it please
fun game. would play again. 8/10
The idea is there but the game was very boring yet very informative
give me more....
hoenstly, theres nothing wrong with this game. theres also just nothing intresting either. It doesnt feel engaging. kind of like an idle cliker mix with a mangment sim? is how i would describe the feeling of the game
Momentum
Pace estimated from the game's recent review growth (our daily snapshots) at its own sales-per-review ratio — a momentum signal, not booked sales.
Audience
Estimated from the language of this game's reviews — a proxy for where players are, not official Steam demographics.
Related
| Hearts of Iron IV | $478.6M | 373.3K | 90% | $49.99 |
| 7 Days to Die | $425.3M | 398.5K | 87% | $44.99 |
| Mount & Blade II: Bannerlord | $309.8M | 294.6K | 88% | $49.99 |
| Stellaris | $277.8M | 196.4K | 86% | $49.99 |
| Arma 3 | $237.7M | 294.4K | 90% | $29.99 |
| Europa Universalis IV | $215.5M | 137K | 88% | $49.99 |